A detailed history of Coppell Advisory Solutions LLC transactions in Novartis Ag stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 209 shares of NVS stock, worth $22,584. This represents 0.0% of its overall portfolio holdings.

Number of Shares
209
Previous 143 46.15%
Holding current value
$22,584
Previous $13 Million 62.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$92.27 - $101.54 $6,089 - $6,701
66 Added 46.15%
209 $21.1 Million
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $11,272 - $12,510
119 Added 495.83%
143 $13 Million
Q2 2023

Aug 17, 2023

BUY
$92.52 - $104.91 $2,220 - $2,517
24 New
24 $2.39 Million
Q1 2023

May 19, 2023

SELL
$80.03 - $92.81 $12,324 - $14,292
-154 Closed
0 $0
Q4 2022

May 19, 2023

SELL
$75.55 - $92.52 $288,449 - $353,241
-3,818 Reduced 96.12%
154 $14 Million
Q4 2020

Mar 10, 2021

BUY
$78.07 - $94.43 $310,094 - $375,075
3,972 New
3,972 $375,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $232B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.